Obserwuj
Anne M Noonan, MBBCHBAO, PhD, MSc, MRCPI
Anne M Noonan, MBBCHBAO, PhD, MSc, MRCPI
Associate Professor, The Ohio State University
Zweryfikowany adres z osumc.edu
Tytuł
Cytowane przez
Cytowane przez
Rok
Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses
JM Lee, JL Hays, CM Annunziata, AM Noonan, L Minasian, JA Zujewski, ...
Journal of the National Cancer Institute 106 (6), dju089, 2014
2192014
Randomized phase 2 trial of the oncolytic virus pelareorep (Reolysin) in upfront treatment of metastatic pancreatic adenocarcinoma
AM Noonan, MR Farren, SM Geyer, Y Huang, S Tahiri, D Ahn, S Mikhail, ...
Molecular Therapy 24 (6), 1150-1158, 2016
1442016
Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
C Akateh, SM Black, L Conteh, ED Miller, A Noonan, E Elliott, TM Pawlik, ...
World journal of gastroenterology 25 (28), 3704, 2019
1292019
Characterization of ovarian cancer cell lines as in vivo models for preclinical studies
L Hernandez, MK Kim, LT Lyle, KP Bunch, CD House, F Ning, ...
Gynecologic oncology 142 (2), 332-340, 2016
1092016
Systemic immune activity predicts overall survival in treatment-naive patients with metastatic pancreatic cancer
MR Farren, TA Mace, S Geyer, S Mikhail, C Wu, K Ciombor, S Tahiri, ...
Clinical cancer research 22 (10), 2565-2574, 2016
982016
Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum‐resistant or‐refractory epithelial ovarian cancer
AM Noonan, KP Bunch, JQ Chen, MA Herrmann, JM Lee, EC Kohn, ...
Cancer 122 (4), 588-597, 2016
902016
Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc).
MJ Overman, P LoRusso, JH Strickler, SP Patel, SJ Clarke, AM Noonan, ...
Journal of Clinical Oncology 36 (15_suppl), 4123-4123, 2018
772018
Immune checkpoint inhibitors in hepatocellular cancer: current understanding on mechanisms of resistance and biomarkers of response to treatment
AE Onuma, H Zhang, H Huang, TM Williams, A Noonan, A Tsung
Gene expression 20 (1), 53, 2020
752020
Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions.
KEC Moon DH, Lee JM, Noonan AM, Annunziata CM
British Journal of Cancer 109 (4), 1072-8, 2013
752013
A phase II study of pembrolizumab in combination with mFOLFOX6 for patients with advanced colorectal cancer.
S Shahda, AM Noonan, TS Bekaii-Saab, BH O'Neil, A Sehdev, WL Shaib, ...
Journal of Clinical Oncology 35 (15_suppl), 3541-3541, 2017
742017
CD200 promotes immunosuppression in the pancreatic tumor microenvironment
F Choueiry, M Torok, R Shakya, K Agrawal, A Deems, B Benner, A Hinton, ...
Journal for immunotherapy of cancer 8 (1), 2020
652020
Randomized phase II study of pet response–adapted combined modality therapy for esophageal cancer: mature results of the CALGB 80803 (Alliance) trial
KA Goodman, FS Ou, NC Hall, T Bekaii-Saab, B Fruth, E Twohy, ...
Journal of Clinical Oncology 39 (25), 2803, 2021
642021
IKK-epsilon coordinates invasion and metastases of ovarian cancer
ACM Hsu S, Kim M, Hernandez L, Grajales V, Noonan A
Cancer Research 72 (21), 5494-504, 2012
62*2012
Next‐generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance
DH Ahn, M Javle, CW Ahn, A Jain, S Mikhail, AM Noonan, C Wu, ...
Cancer 122 (23), 3657-3666, 2016
522016
Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice
KM Huang, AF Leblanc, ME Uddin, JY Kim, M Chen, ED Eisenmann, ...
The Journal of clinical investigation 130 (9), 4601-4606, 2020
512020
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers
M Yarchoan, L Cope, AN Ruggieri, RA Anders, AM Noonan, LW Goff, ...
The Journal of Clinical Investigation 131 (24), 2021
492021
Electrocardiographic Studies of Romidepsin Demonstrate Its Safety and Identify a Potential Role for KATP Channel
AM Noonan, RA Eisch, DJ Liewehr, TM Sissung, DJ Venzon, TP Flagg, ...
Clinical Cancer Research 19 (11), 3095-3104, 2013
492013
Implementing a multidisciplinary approach for older adults with cancer: geriatric oncology in practice
CJ Presley, JL Krok-Schoen, SA Wall, AM Noonan, DC Jones, E Folefac, ...
Bmc Geriatrics 20, 1-9, 2020
452020
A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis
DH Ahn, K Krishna, M Blazer, J Reardon, L Wei, C Wu, KK Ciombor, ...
Therapeutic Advances in Medical Oncology 9 (2), 75-82, 2017
452017
Adjuvant nab-paclitaxel+ gemcitabine in resected pancreatic ductal adenocarcinoma: results from a randomized, open-label, phase III trial
MA Tempero, U Pelzer, EM O'Reilly, J Winter, DY Oh, CP Li, G Tortora, ...
Journal of Clinical Oncology 41 (11), 2007, 2023
422023
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20